SCHEMBL10270122

SCHEMBL10270122

CC(C)[C@H]1CC[C@@H](C(=O)N2CCN[C@@H](C)C2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 8/20 0.50
CHRNA3 P32297 8/20 0.50
CHRNA4 P43681 8/20 0.50
CHRNB3 Q05901 3/20 0.50
CHRNA6 Q15825 3/20 0.50
BIRC2 Q13490 1/20 0.37
HPGD P15428 1/20 0.37
CHRNB4 P30926 5/20 0.37
CHRNA7 P36544 5/20 0.37
MAPT P10636 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
PLD1 Q13393 2/20 0.35
PLD2 O14939 1/20 0.35
KMT2A Q03164 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
HTT P42858 1/20 0.34
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24069213 0.89 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15076330 0.89 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL10270228 0.84 CHRNB2 (0.72) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL25855485 0.84 CHRNB2 (0.72) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15199121 0.84 CHRNB2 (0.56) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15058915 0.82 CHRNB2 (0.53) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15058918 0.82 CHRNB2 (0.53) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL24322634 0.81 TSHR (0.55) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL26494226 0.77 HPGD (0.52) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL25094702 0.76 DPP4 (0.44) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed